help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ward, B. K.
Right arrow Articles by Ratajczak, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, B. K.
Right arrow Articles by Ratajczak, T.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 8 3721-3730
Copyright © 2004 by The Endocrine Society


Clinical Case Seminar

Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism

Bryan K. Ward, Aaron L. Magno, Elizabeth A. Davis, Aylin C. Hanyaloglu, Bronwyn G. A. Stuckey, Mark Burrows, Karin A. Eidne, Adrian K. Charles and Thomas Ratajczak

UWA Centre for Medical Research (B.K.W., A.L.M., A.C.H., K.A.E., T.R.), the University of Western Australia, Nedlands, Western Australia 6009; Department of Endocrinology and Diabetes (B.K.W., A.L.M., B.G.A.S., T.R.), Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009; and Departments of Endocrinology (E.A.D., M.B.) and Pathology (A.K.C.), Princess Margaret Hospital, Subiaco, Western Australia 6008

Address all correspondence and requests for reprints to: Thomas Ratajczak, Department of Endocrinology and Diabetes, Block C, Queen Elizabeth II Medical Centre, Hospital Avenue, Nedlands, Western Australia 6009, Australia. E-mail: tomr{at}cyllene.uwa.edu.au.

Heterozygous inactivating mutations of the calcium-sensing receptor (CaR) cause familial hypocalciuric hypercalcemia, whereas homozygous or compound heterozygous inactivating mutations normally cause neonatal severe hyperparathyroidism. In a case of neonatal severe hyperparathyroidism characterized by moderately severe hypercalcemia and very high PTH levels, coupled with evidence of hyperparathyroidism and effects on brain development not previously demonstrated, we detected point mutations on separate alleles of the CaR, resulting in premature stop codon substitutions at G94 and R648. This led to severely truncated receptors and an effective so-called knockout of functional CaR. FLAG-tagged, truncated receptors were expressed in HEK293 cells for functional analysis. Confocal microscopy demonstrated cytoplasmic localization of the G94stop receptor, whereas the R648stop receptor was present both in the cytoplasm and associated with the cell membrane. Only the R648stop receptor could be detected by Western analysis. Functional assays in which R648stop and wild-type receptor were cotransfected into HEK293 cells demonstrated a reduction in wild-type Ca2+-responsiveness by the R648stop receptor, even at physiological Ca2+ levels, thus simulating familial hypocalciuric hypercalcemia in relatives of the infant who were heterozygous for the R648stop mutation. The R648stop receptor alone was nonresponsive to Ca2+. This case contributes to our understanding of the clinical manifestation of a CaR knockout.

This work was supported by grants from the Sir Charles Gairdner Hospital Research Fund, the Medical Research Fund of Western Australia, and the Raine Foundation for Medical Research.

Abbreviations: Ab, Antibody; CaR, calcium-sensing receptor; CT, computerized tomography; FCS, fetal calf serum; FHH, familial hypocalciuric hypercalcemia; IP, inositol phosphate; NSHPT, neonatal severe hyperparathyroidism; PI-PLC, phosphoinositide-specific phospholipase C; TBS, Tris-buffered saline.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. S. Hurtel-Lemaire, R. Mentaverri, A. Caudrillier, F. Cournarie, A. Wattel, S. Kamel, E. F. Terwilliger, E. M. Brown, and M. Brazier
The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis: NEW INSIGHTS INTO THE ASSOCIATED SIGNALING PATHWAYS
J. Biol. Chem., January 2, 2009; 284(1): 575 - 584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society